Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...

Praxis Precision Medicines Inc. (NASDAQ: PRAX) stock rose Monday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for ulixacaltamide for essential ...

As the country continues to face a shortage of neurologists, residents in rural West Texas are feeling the impact, especially ...

Up to 189 health conditions could potentially affect your ability to drive, with seven specific conditions that must be ...

After several hours playing through an exclusive, hands-on demo of Cairn, the upcoming climbing-survival sim, we were riveted ...

National nutrition surveys show that many of us are lacking key nutrients. We look at the most common deficiencies and how to ...

Wanja trusted Wambua during her most vulnerable moment. His betrayal forces her to walk away and rebuild a life defined by ...

When anxiety spikes, the nervous system can shift into fight-or-flight in seconds, but it can also be guided back toward ...

For nearly two decades, Nduta’s body has been at war with itself. Her fight for a diagnosis and dignity rewrites the story of ...

Essential tremor is a neurological condition which causes involuntary trembling - most commonly in the hands and arms, but ...

Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor. Praxis on ...

The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential tremor Praxis remains on track to submit ulixacaltamide NDA in ...